Advances in Chronic Kidney Disease
Volume 13, Issue 1 , Pages 56-61 , January 2006

Chronic Allograft Nephropathy

  • Pankaj Baluja

      Affiliations

    • Department of Medicine, University of Oklahoma, Oklahoma City, OK
    • Department of Pathology, University of Oklahoma, Oklahoma City, OK
    • ,
  • Lukas Haragsim

      Affiliations

    • Department of Medicine, University of Oklahoma, Oklahoma City, OK
    • Department of Pathology, University of Oklahoma, Oklahoma City, OK
    • Corresponding Author InformationAddress Correspondence to Lukas Haragsim, MD, Associate Professor of Medicine, University of Oklahoma Health Science Center, Oklahoma City, OK 73104.
    • ,
  • Zoltan Laszik

      Affiliations

    • Department of Medicine, University of Oklahoma, Oklahoma City, OK
    • Department of Pathology, University of Oklahoma, Oklahoma City, OK

References 

  1. Hostetter TH . Chronic transplant rejection . Kidney Int . 1994;46:266–279
  2. Carpenter CB . Long-term failure of renal transplants (Adding insult to injury) . Kidney Int . 1995;48:40
  3. Halloran PF , Melk A , Barth C . Rethinking chronic allograft nephropathy (The concept of accelerated senescence) . J Am Soc Nephrol . 1999;10:167–181
  4. Manoco AP , Burke JF , Ferguson RM , et al.   Current thinking on chronic renal allograft rejection (Issues, concerns, and recommendations from a 1997 roundtable discussion) . Am J Kidney Dis . 1999;33:150–160
  5. Yakupoglu U , Baranowska-Daca E , Rosen D , et al.   Post-transplant nephrotic syndrome (A comprehensive clinicopathologic study) . Kidney Int . 2004;65:2360–2370
  6. Kasiske BL , Kalil RS , Lee HS , et al.   Histopathological findings associated with a chronic progressive decline in renal allograft function . Kidney Int . 1991;40:514–524
  7. Gouldesbrough BR , Axelsen RA . Arterial endothelialitis in chronic allograft rejection (A histopathological and immunohistological study) . Nephrol Dial Transplant . 1994;9:35–40
  8. Racusen LC , Solez K , Colvin RB , et al.   The Banff 97 working classification of renal allograft pathology . Kidney Int . 1999;55:713–723
  9. Solez K , Benediktsson H , Cavallo T , et al.   Report of the Third Banff Conference on Allograft Pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathology . Transplant Proc . 1996;28:441–444
  10. Maryniak RK , First MR , Weiss MA . Transplant glomerulopathy (Evolution of morphologically distinct changes) . Kidney Int . 1985;27:799–806
  11. Kasiske BL , Kalil RS , Lee HS , et al.   Histopathologic findings associated with a chronic, progressive decline in renal allograft function . Kidney Int . 1991;40:514–524
  12. Monga G , Mazzucco G , Massina M , et al.   Intertubular capillary changes in kidney allografts (A morphologic investigation on 61 renal specimens) . Mod Pathol . 1992;5:125–130
  13. Nankivell BJ , Borrows RJ , Chir B , et al.   The natural history of chronic allograft nephropathy . N Engl J Med . 2003;349:2326–2333
  14. Matas AJ , Gillingham KJ , Humar A , et al.   Immunologic and nonimmunologic factors (Different risks for cadaver and living donor transplantation) . Transplantation . 2000;69:54
  15. Andredottir MB , Assman KJ , Koene RA , et al.   Immunohistological and ultrastructural differences between recurrent type 1 memranoproliferative glomerulonephritis and chronic transplant glomerulopathy . Am J Kidney Dis . 1998;32:582
  16. Tullius SG , Tilney NL . Both allogen-dependent and -independent factors influence chronic allograft rejection . Transplantation . 1995;59:313–318
  17. Krieger NR , Becker BN , Heisey DM , et al.   Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts . Transplantation . 2003;75:1677–1682
  18. Almond PS , Matas A , Gillingham KJ , et al.   Risk factors for chronic rejection in renal allograft recipients . Transplantation . 1993;55:752–756
  19. Basadonna GP , Matas AJ , Gillingham KJ , et al.   Early versus late acute renal allograft rejection (impact on chronic rejection) . Transplantation . 1993;55:993–995
  20. Matas AJ , Gillingham KJ , Payne WD , et al.   The impact of an acute rejection episode on long-term renal allograft survival (t1/2) . Transplantation . 1994;57:857–859
  21. Humar A , Kerr S , Gillingham KJ , Matas AJ . Features of acute rejection that increase risk for chronic rejection . Transplantation . 1999;68:1200–1203
  22. Humar A , Payne WD , Sutherland DE , et al.   Clinical determinants of multiple acute rejection episodes in kidney transplant recipients . Transplantation . 2000;69:2357–2360
  23. Lindholm A , Ohlman S , Albrechtsen D , et al.   The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens . Transplantation . 1993;56:307–315
  24. Terasaki PI , Ozawa M . Predicting kidney graft failure by hla antibodies (a prospective trial) . Am J Transplant . 2004;4:438–443
  25. Cecka JM , Cho L . Sensitization . In:  Terasaki PI editors. Clinical Transplants 1988 . Los Angeles, CA: UCLA Tissue Typing Laboratory; 1989;p. 365
  26. Hata Y , Ozawa M , Takemoto S . HLA matching . In:  Terasaki PI editors. Clinical Transplants 1996 . Los Angeles, CA: UCLA Tissue Typing Laboratory; 1997;p. 381
  27. Zantvoort FA , D’Amaro J , Persijn GG , et al.   The impact of HLA-A matching on long-term survival of renal allografts . Transplantation . 1996;61:841–844
  28. Ponticelli C , Villa M , Cesana B , et al.   Risk factors for late kidney allograft failure . Kidney Int . 2002;62:1848–1854
  29. van der Hoeven JA , Molema G , Ter Horst GJ , Freund RL . Relationship between duration of brain death and hemodynamic (in)stability on progressive dysfunction and increased immunologic activation of donor kidneys . Kidney Int . 2003;64:1874–1882
  30. Lu CY , Penfield JG , Keilar M , et al.   Hypothesis (Is renal allograft rejection initiated by the response to injury sustained during the transplant process?) . Kidney Int . 1999;55:2157–2168
  31. Parschke J , Vok HD . Brain death-associated ischemia and reperfusion injury . Curr Opin Organ Transplant . 2004;9:153
  32. Yokoyama I , Uchida K , Kobayashi T , et al.   Effect of prolonged delayed graft function on long-term outcome in cadaveric kidney transplantation . Clin Transplant . 1994;8:101–106
  33. Peters TG , Shaver TR , Ames JT , et al.   Cold ischemia and outcome in 17,937 cadaveric kidney transplants . Transplantation . 1995;59:191–196
  34. Polyak MM , Arrington BO , Stubenbord WT , et al.   The influence of pulsatile preservation on renal transplantation in the 1990’s . Transplantation . 2000;69:249–258
  35. Stokes KY , Abdih HK , Kelly CJ , et al.   Thermotolerance attenuates ischemia-reperfusion induced renal injury and increased expression of ICAM-1 . Transplantation . 1996;62:1143–1149
  36. Waldman WJ , Knight DA . Cytokine-mediated induction of endothelial adhesion molecule and histocompatability leukocyte antigen expression by cytomegalovirus-activated T cells . Am J Pathol . 1996;148:105–119
  37. Bia MJ . Nonimmunologic causes of late renal graft loss . Kidney Int . 1995;47:1470–1480
  38. Melk A , Gourishankar S , Halloran PF . Long-term effects of nonimmune tissue injury in renal transplantation . Curr Opin Organ Transplant . 2002;7:171–177
  39. Bhathena DB . Glomerular size and the association of focal glomerulosclerosis in long-surviving human renal allografts . J Am Soc Nephrol . 1993;4:1316–1326
  40. Sanders CE , Curtis JJ . Role of hypertension in chronic renal allograft dysfunction . Kidney Int . 1995;52(suppl):S43–S47
  41. Cheigh JS , Haschemeyer RH , Wang JC , et al.   Hypertension in kidney transplant recipients. Effect on long-term renal allograft survival . Am J Hypertens . 1989;2:341–348
  42. Kasiske BL , Anjum S , Shah R , et al.   Hypertension after kidney transplantation . Am J Kidney Dis . 2004;43:1071–1081
  43. Meier-Kriesche HU , Schold JD , Srinivas TR , et al.   Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era . Am J Transplant . 2004;4:378–383
  44. Kim SJ , Schaubel DE , Jeffery JR , et al.   Centre-specific variation in renal transplant outcomes in Canada . Nephrol Dial Transplant . 2004;19:1856–1861
  45. Opelz G . The benefit of exchanging donor kidneys among transplant centers . N Engl J Med . 1988;318:1289–1292
  46. Melk A , Halloran P . Immunosuppressive agents used in transplantation . In:  Johnson RJ editors. Comprehensive Clinical Nephrology . Philadelphia, PA: Mosby; 2000;p. 1057
  47. Sells RA , Bakran A , Brown MW , et al.   A prospective randomized study of CsA monotherapy versus CsA + mycophenolate mofetil in cadaveric renal recipients . 1998; Program and Abstracts of the 3rd International Conference on New Trends in Clinical and Experimental Immunosuppression. Geneva, Switzerland, Feb 12-15
  48. Weir M , Anderson L , Fink J , et al.   A novel approach to the treatment of chronic allograft nephropathy . Transplantation . 1997;64:1706–1710
  49. Dudley C , Pohanka E , Riad H , et al.   Mycophenolate mofetil substitution for cyclosporine a in renal transplant recipients with chronic progressive allograft dysfunction (The “Creeping Creatinine” Study) . Transplantation . 2005;79:466–475
  50. Lin J , Valeri Am , Markowitz GS , et al.   Angiotensin converting enzyme inhibition in chronic allograft nephropathy . Transplantation . 2002;73:783–788
  51. Zaltzaman JS , Nash M , Chiu R , et al.   The benefits of renin-angiotensin blockade in renal transplant recipients with biopsy proven allograft nephropathy . Nephrol Dial Transplant . 2004;19:940–944

PII: S1548-5595(05)00205-3

doi: 10.1053/j.ackd.2005.11.004

Advances in Chronic Kidney Disease
Volume 13, Issue 1 , Pages 56-61 , January 2006

Article Tools

* Image Usage & Resolution